ATU iHub client company InVera Medical has announced positive 12-month results from its pilot clinical study of the InVera Infusion Device for the treatment of Chronic Venous Disease (CVD). The findings were presented at the Charing Cross Symposium in London by Dr....
KinetikIQ, an ATU iHubs Innovator, Secures Symvan Capital Backing We’re delighted to congratulate Emma Meehan, CEO, CTO and Founder of KinetikIQ, on joining the Symvan Capital SEIS portfolio. KinetikIQ has developed an innovative software platform delivering real-time...
Four ATU iHub Leaders Honoured in ThinkBusiness ‘Women-Led Start-Ups to Watch 2026’ This year’s shortlist includes founders at different stages of their entrepreneurial journeys, from alumni to current iHub clients, all united by a commitment to solving meaningful...
Watch Video of the SechMed Talk Galway, Ireland – Tuesday 22nd April – SechMed, in partnership with ATU iHubs Galway, hosted a Lunch & Learn session focused on strengthening the early stages of medical device development and helping innovators...
iHub client company InVera Medical Receives FDA Clearance for InVera Infusion Device – a Novel Non-Thermal Catheter for Enhanced Infusion of Sclerosant for Chronic Venous Disease GALWAY, Ireland, April 7, 2026 /PRNewswire/ — InVera Medical, a medical...
The ATU Innovation Hub Mayo is proud to celebrate a significant milestone: 20 years since opening its doors on 20 March 2006. What began as the Innovation in Business Centre has evolved through the GMIT Innovation Hub and into today’s ATU Innovation Hub, but one thing...
